March 9, 2020 / 9:38 PM / 21 days ago

BRIEF-Crinetics Pharmaceuticals Reports Q4 Loss Per Share Of $0.60

March 9 (Reuters) - Crinetics Pharmaceuticals Inc:

* CRINETICS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* CRINETICS PHARMACEUTICALS INC QUARTERLY LOSS PER SHARE $0.60

* CRINETICS PHARMACEUTICALS INC QUARTERLY GRANT REVENUES $321,000 VERSUS $781,000

* CRINETICS PHARMACEUTICALS - EXPECTS THAT CASH, CASH EQUIVALENTS AND INVESTMENTS WILL FUND CURRENT OPERATING PLAN INTO SECOND HALF OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below